menu

Medical Industry Feature: The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)

Program Information
Recommended
The Role of Clonal Evolution and Deletion 17p in Chronic Lymphocytic Leukemia (CLL)
RestartResume
Dr. Matt Birnholz and Dr. Nicole Lamanna discuss Chronic Lymphocytic Leukemia (CLL): how it's characterized, diagnosed, and tested.
  • Sponsored by

  • Overview

    In this program, Dr. Matt Birnholz is joined by Dr. Nicole Lamanna, Associate Professor of Medicine in the Hematologic Malignancies Section at Columbia University Medical Center, New York to discuss Chronic Lymphocytic Leukemia (CLL), the role of clonal evolution and deletion 17p in CLL, and how this disease is characterized, diagnosed and tested.

    This module is intended for United States and Puerto Rico health care professionals only and was developed by Abbvie.

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/13/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.